MedPath

The effect of dill vaginal cream on treatment of candida vaginitis

Phase 2
Conditions
vulvovaginal Candidiasis.
Candidiasis of vulva and vagina
Registration Number
IRCT2016071929004N1
Lead Sponsor
Vice chancellor for research, Kerman University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
105
Inclusion Criteria

sign and symptoms of vulvovaginal candidiasis; married women; between 18 to 65 years old; with positive sniff test; without pregnancy, without breast feeding, without chronic disease such as (kidney ,liver, cardiac disease and diabetes ), no existance of immunodeficiency nor complicated vaginal candidiasis on diagnosis of gynecologist and not using of systemic antibiotics and immunosuppressive drugs, or any vaginal drugs during the study and not using of systemic anti fungal drugs since 4 weeks ago.
Exclusion criteria: side effects or drug reaction; pregnancy; menstruate; lack of patient's association.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Burning. Timepoint: at the beginning and 10 days after intervention. Method of measurement: Evaluation of clinical symptom's remission(burning) with VSQ (vulvovaginal symptom questionnaire).;Itching. Timepoint: at the beginning and 10 days after intervention. Method of measurement: Evauation of clinical symptom's remission (itching) with VSQ (vulvovaginal symptom questionnaire).;Vaginal discharge. Timepoint: at the beginning and 10 days after intervention. Method of measurement: Evaluation of clinical symptom's remission (vaginal discharge) with VSQ (vulvovaginal symptom questionnaire).;Erithema. Timepoint: at the beginning and 10 days after intervention. Method of measurement: physical exam.;Edema. Timepoint: at the beginning and 10 days after intervention. Method of measurement: physical exam.
Secondary Outcome Measures
NameTimeMethod
Sniff test outcome. Timepoint: at the beginning and 10 days after intervention. Method of measurement: vaginal smear.
© Copyright 2025. All Rights Reserved by MedPath